Skip to Navigation Skip to Search Skip to Content
Search All Centers

How Can Acute Lymphoblastic Leukemia Treatment Be Tailored?

Read Transcript
View next

Published on March 15, 2016

Dr. Elias Jabbour from The University of Texas MD Anderson Cancer Center explains how patients' individual circumstances affect treatment decisions. Age is an important factor for chemotherapy, with older patients being at risk if high dose is used. Pros and cons need to be considered in order to maximise treatment outcome, with cure being the ultimate goal for every patient.

Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, at Orlando, FL.


Your site is AWESOME! Thank you all so much for this incredible resource to families who are in crisis/affected by cancer.

— Loyal Patient Power viewer

Transcript | How Can Acute Lymphoblastic Leukemia Treatment Be Tailored?

Dr. Jabbour:

Definitely we are aiming for the cure.  If the aim of the cure, then you have to think differently.  Today if, God forbid I have leukaemia myself, I want to get the best treatment that can optimise my cure rate.  Now if you have somebody who is 80 years old it’s different than somebody 40, correct?  Then you have to worry about safety concerns because you don’t want to harm them from the chemo you are offering.  With somebody young you know the chances [?] are good.

And then I tell them, well look at your disease, let’s identify your disease, what you have, the pros and cons and if you have something we consider bad features let’s see how we can overcome its weight with adding or at least personalise the treatment to you.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View next